DEF: Accuray Seeks Stockholder Approval for Financing and Nasdaq Compliance Measures

Accuray Incorporated is holding a special meeting on October 6, 2026, to seek stockholder approval for a crucial financing transaction involving preferred stock issuance and warrants, alongside a reverse stock split to regain Nasdaq compliance.

Summary

• Accuray Incorporated is convening a special meeting of stockholders on October 6, 2026, to vote on several proposals critical to a financing transaction and its continued listing on the Nasdaq Capital Market.
• The financing transaction includes the issuance of $55 million in Series A Convertible Preferred Stock, with $15 million in cash and $40 million from the conversion of existing debt held by investors.
• Warrants to purchase approximately 15.3 million shares of common stock at $0.01 per share have also been issued.
• Stockholder approval is required for the issuance of shares exceeding 19.99% of outstanding common stock, an increase in authorized shares from 200 million to 400 million, and a reverse stock split with a ratio between 1-for-15 and 1-for-40.
• The reverse stock split is intended to increase the per-share trading price to meet Nasdaq's minimum bid price requirement of $1.00.
• The company's Board of Directors unanimously recommends voting FOR all four proposals.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this filing as having a negative sentiment due to significant dilution, a reverse stock split to maintain Nasdaq compliance, and the potential for continued financial challenges despite a capital infusion.

Positives

• The financing transaction provides $15 million in new cash to support transformation initiatives and working capital.
• The conversion of $40 million in debt reduces the company's overall indebtedness and future interest expense.
• The financing agreement includes a covenant holiday through December 31, 2027, providing operational flexibility.
• The company is taking steps to regain compliance with Nasdaq listing requirements, aiming to maintain its listing.

Negatives

• The issuance of Series A Preferred Stock and warrants will result in significant dilution to existing stockholders, potentially increasing outstanding shares by 92% upon conversion.
• The company is facing delisting from the Nasdaq Capital Market due to its stock price falling below the $1.00 minimum bid price requirement.
• A reverse stock split is required, which can be viewed negatively by investors and may not guarantee an increase in stock price or market capitalization.
• The company's stock price has been below the $1.00 minimum bid price for an extended period, indicating ongoing market concerns.

Risks

• The risk that the conditions to closing the financing transaction may not be satisfied.
• The risk that the reverse stock split may not result in an increase to the common stock price or that the company may be unable to maintain its Nasdaq listing.
• Significant dilution to existing stockholders' ownership and voting interests.
• The potential for Nasdaq to exercise discretionary authority to delist securities due to substantial dilution.
• TCW and its affiliates will have significant influence over the company post-transaction, potentially leading to conflicts of interest with other stockholders.
• The possibility that the reverse stock split may decrease the liquidity of the common stock and result in higher transaction costs.

Future Outlook

The company is seeking stockholder approval for a financing transaction and a reverse stock split to strengthen its financial position, ensure continued listing on Nasdaq, and support its transformation initiatives. The success of these measures is contingent on stockholder approval and Nasdaq's continued listing requirements.

Management Comments

• The Board believes the Financing Transaction represents an important step in supporting our financial and strategic objectives and creating long-term stockholder value.
• The Board unanimously determined that the Financing Transaction and the proposals described in this Proxy Statement are advisable and in the best interests of the Company and our stockholders.
• The Board unanimously recommends that our stockholders vote FOR each proposal presented at the Special Meeting.
• The Board determined that a comprehensive recapitalization transaction represented the most effective path to strengthen our balance sheet, improve liquidity, ensure that we could continue as a going concern, execute on our long-term strategic plan, and support long-term value creation for our stockholders.
• The Board has determined that it is advisable and in the best interests of the Company and its stockholders to reduce the number of shares of Common Stock outstanding with the primary intent of increasing the per share trading price of the Common Stock in order to meet the listing requirements of The Nasdaq Capital Market.

Industry Context

StockSavvy.ai notes that Accuray operates in the medical device sector, specifically focused on radiation oncology. Companies in this sector often face challenges related to R&D investment, regulatory approvals, and market competition. Maintaining Nasdaq listing is crucial for access to capital and investor confidence, making the proposed reverse stock split and financing a critical move for the company's survival and future growth prospects.

Management Changes

Corporate Governance

Related Party Transactions

• The financing transaction involves existing investors (TCW and affiliates) who are lenders under the Financing Agreement.
• Steven F. Mayer, a director, has a relationship with TCW, an affiliate of the lead investor, and may be deemed to have an interest in the Nasdaq Stock Issuance Proposal.
• Chan W. Galbato, a director, serves on a corporate advisory board at TCW and receives consulting compensation.

Stakeholder Impact

• Shareholders will experience significant dilution in ownership and voting power due to the issuance of preferred stock and warrants.
• Shareholders may see a decrease in the per-share trading price if the reverse stock split does not achieve its intended effect or if market conditions are unfavorable.
• The company's ability to maintain its Nasdaq listing is critical for investor confidence and future financing opportunities.
• Creditors may benefit from the reduction in indebtedness and improved financial flexibility.
• Employees may be impacted by potential changes in company strategy and financial performance.

Next Steps

• Stockholders must vote on the four proposals at the Special Meeting on October 6, 2026.
• If approved, the company will proceed with the financing transaction and potentially effect the reverse stock split.
• The company will file a Certificate of Amendment to its Certificate of Incorporation to implement the authorized shares increase and/or the reverse stock split.
• The company will file a resale registration statement for shares issuable upon conversion of Series A Preferred Stock and exercise of warrants.

Key Dates

Recommendation

The company is in a precarious financial position, requiring significant financing and a reverse stock split to maintain its Nasdaq listing. While the financing provides much-needed capital and debt reduction, the substantial dilution and the uncertainty surrounding the effectiveness of the reverse stock split present significant risks. A 'hold' recommendation reflects a cautious approach, acknowledging the potential for recovery if the strategic initiatives are successful, but also recognizing the considerable downside risks.

Keywords

financing transaction, reverse stock split, Nasdaq compliance, preferred stock, warrants, stockholder approval, capital raise, dilution